Implementation of exome sequencing for rare undiagnosed diseases in LMICs: the G2MC rare diseases exome sequencing pilot project

Yasas D. Kolambage C. Gonzaga-Jauregui Guillermo Lay-Son Rupesh Mishra N. Mabaso S. Tae Kristin A. Maloney C. Galaz-Montoya Dineshani Hettiarachchi B. Dillon Nilam Thakur L. de Menten Cecilia Mellado C. Greene Toni I. Pollin A. Krause M. Thong A. Shuldiner V. Dissanayake

Jul 2026 · Human Genetics · Vol 145 · 0 citations · 26 references

Medicine

TL;DR

The feasibility, effectiveness, and adaptability of implementing exome sequencing in resource-limited settings are demonstrated and its potential to transform rare disease diagnosis and care in low- and middle-income countries is highlighted.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Sep 2026

Genomic Research as a Critical Pathway to Diagnosis for Individuals with Rare Disease

Many individuals with rare monogenic disease remain molecularly undiagnosed due to challenges accessing genetic testing, ambiguity in interpretation of uncertain variants, and latency between novel disease-gene discovery and adoption into clinical pipelines. The Rare Genomes Project (RGP) provides a remote, research-ba...

A. O'Donnell-Luria, S. DiTroia, Melanie C. O'Leary et al. · medRxiv · 0 citations

Review Open access Aug 2026

Detecting pathogenic structural variation in families with undiagnosed rare disease in a national genome project.

Whole-genome sequencing (WGS) projects for rare disease diagnosis typically yield a diagnostic rate of 25-41%, depending on the methods for patient selection and the extent of prior genetic testing. The Scottish Genomes Partnership (SGP) is a collaborative programme using genome sequencing to diagnose rare disease pati...

P. Dutta, A. Pagnamenta, Christelle Robert et al. · European Journal of Human Ge... · 0 citations

Open access Jan 2026

Whole‐Exome Sequencing in Undiagnosed Muscular Dystrophies: A High Diagnostic Yield and Novel Insights From Iranian Families

This study expands the mutational spectrum of MDs in Iran and provides critical data for genetic counseling, prenatal diagnosis, and future therapeutic development, and underscores the importance of population‐specific genomic studies.

Nasibeh Soltani, Zahra Shahbazi, M. Fallah et al. · Human Mutation · 0 citations

Sep 2026

Proteomics identify disease-associated variants in patients with rare diseases undiagnosed after genome sequencing.

Despite the introduction of genome sequencing (GS) for rare disease diagnostics, a genetic cause is not identified in most patients. Here, we explored the potential of proteomics to improve the diagnostic yield in 424 patients with rare diseases from the 100,000 Genomes Project (100kGP) without a genetic diagnosis. Ser...

J. Carrasco-Zanini, J. Andrade, M. Pietzner et al. · Science Translational Medici... · 0 citations

Open access Aug 2026

Whole-exome sequencing reveals the genetic landscape and polygenic susceptibility in 1241 patients with clinically suspected hemophagocytic lymphohistiocytosis

Hemophagocytic lymphohistiocytosis (HLH) is a severe immunological disorder characterized by dysregulated immune activation. Pathogenic variants in HLH-causative genes serve as diagnostic criteria and guide treatment decisions. However, known genes do not fully explain the molecular basis of many cases, and the pol...

Yu-Huan Meng, Mao-Ting Shen, Shu-yi Guo et al. · npj Genomic Medicine · 0 citations

Open access Sep 2026

Genome sequencing improves diagnostic outcomes over panel and exome sequencings in myopathies: findings from the French PFMG2025 initiative

Myopathies represent a very heterogeneous group of disease with multiple underlying causes, challenging for molecular genetic diagnosis. Hence, the diagnostic yield is very variable within the different myopathy subtypes. Current diagnostic strategies mainly rely on gene-panel or exome sequencing (ES) approaches,...

Camille Verebi, A. Maino, C. Métay et al. · Genome Medicine · 0 citations